click below
click below
Normal Size Small Size show me how
BDK: PAIN/HEMA/ONC 3
25-26 LIST
| GENERIC | BRAND | CATEGORY | INDICATION | SIDE EFFECTS | BOXED WARNING | NOTES |
|---|---|---|---|---|---|---|
| Methotrexate | Trexall | Antimetabolite (Folic Acid Antagonist) | Rheumatoid arthritis, Crohn’s Disease, psoriasis, various hematologic and solid tumors | stomatitis, diarrhea, nausea, vomiting, thrombocytopenia, leukopenia, increased hepatic transaminases, pulmonary fibrosis (rare) | serious toxic reactions, may cause fetal death and/or congenital abnormalities (avoid in pregnancy); severe (sometimes fatal) bone marrow suppression, aplastic anemia, and toxicity have been reported with concomitant administration of methotrexate and NSAIDs; may cause hepatotoxicity; methotrexate-induced lung disease, including acute or chronic interstitial pneumonitis may occur; severe (sometimes fatal) gastrointestinal toxicity has been reported with concomitant administration with NSAIDs | Folic acid supplementation may be taken during use to reduce hematologic, gastrointestinal, and hepatic side effects |
| Cisplatin | Kemoplat | Antineoplastic Agent, Platinum-Based Compound | Advanced bladder, ovarian, and testicular cancer; various cancers | bone marrow suppression, nausea, vomiting, nephrotoxicity, neurotoxicity, ototoxicity | may cause severe myelosuppression, nausea and vomiting, renal toxicity, and dose-related neuropathy | |
| Doxorubicin | Adriamycin | Antineoplastic Agent, Anthracycline | Adjuvant therapy for breast cancer, various cancers | cardiomyopathy, alopecia, nausea, vomiting, bone marrow suppression | may cause cardiomyopathy, myelosuppression, secondary malignancies; extravasation can result in severe local tissue injury and necrosis | may cause red discoloration of urine, tears, sweat, and saliva |
| Pembrolizumab | Keytruda | Antineoplastic Agent, Monoclonal Antibody | Various Cancers | peripheral edema, pruritus, skin rash, endocrine and metabolic abnormalities, constipation, diarrhea, nausea, vomiting, hematuria, anemia, increased liver enzymes, fatigue, musculoskeletal pain, increased serum creatinine, dyspnea | ||
| Anastrozole | Arimidex | Aromatase Inhibitor | Hormone Receptor-Positive Breast Cancer | fatigue, rash, flushing, hot flashes, arthralgia, nausea, vomiting, hypertension, peripheral edema, osteoporosis | cardiovascular side effects (i.e., hypercholesterolemia, CAD); fetal toxicity (CI in pregnancy) | |
| Tamoxifen | Soltamox | Selective Estrogen Receptor Modulator (SERM) | Hormone Receptor-Positive Breast Cancer | hot flashes/night sweats, vaginal bleeding/discharge, decreased bone density (in premenopausal females) | increased risk for uterine or endometrial cancer and thromboembolic events | contraception should be used in premenopausal females due to teratogenicity of the drug; do not use with warfarin or history DVT/PE |